Idera Pharmaceuticals Inc. (AMEX: IDP), a biopharmaceutical company focused on developing therapeutics targeting Toll-like Receptors (TLRs), today reported financial results for the three and six months ended June 30, 2006.
Idera Pharmaceuticals Inc. (AMEX: IDP), a biopharmaceutical company focused on developing therapeutics targeting Toll-like Receptors (TLRs), today reported financial results for the three and six months ended June 30, 2006.
